AI promised to speed up drug discovery, but the real bottleneck is in clinical trials. This startup is using AI to accelerate ...

With multiple von Willebrand disease therapies approaching clinical trials, columnist Jennifer Lynne is excited about the future of treatment.

For over a decade, the standard of care for high-risk MDS has remained a class of drugs called hypomethylating agents (HMAs).

In the U.S., one in eight women will get breast cancer in their lifetime, and about half of them will have mastectomies. Many ...

The U.S. Food and Drug Administration (FDA) will now allow food labels to claim products have "no artificial colors" as long ...

Sandoya contemplates AI scribes and raises concerns about their potential impact on the quality of clinical information and ...

I spend a lot of time talking with founders about AI - when to adopt it, what to ignore, how to tell signal from noise. And ...

United Therapeutics Corporation uses strong cash flows to develop xenotransplanted organs and solve global supply shortages.

Hospitalist-led research is investigating how AI tools affect clinical reasoning, diagnostic accuracy, and workflow, while ...

Telehealth isn’t new, but the way it’s being used has changed a lot. What started as quick video calls for minor issues is now becoming a real part of everyday medical care. In 2026, many patients are ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech ...

How can AI help streamline measurement-based care in my organization without disrupting existing workflows? Does AI-driven ...